Interleukin-6 Receptor Antagonist [EPC]

Known as: Interleukin 6 Receptor Antagonist, IL-6 Receptor Antagonist, Interleukin-6 (IL-6) Receptor Antagonist 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-2017
0119982017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Lung fibrosis (LF) is a chronic and progressive lung disease characterized by pulmonary parenchyma progressive lesion… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2011
2011
OBJECTIVE The aim of this study was to test whether a functional polymorphism (-174C/G) located in the promoter region of the… (More)
Is this relevant?
2010
2010
UNLABELLED Multiple myeloma (MM) is characterised as a malignant plasma cell proliferation. Interleukin-6 (IL-6) is an important… (More)
  • table 1
  • table 1
  • table 2
Is this relevant?
2006
2006
Interleukin-6 (IL-6) affects the survival and proliferation of myeloma cells via autocrine and/or paracrine mechanisms. In this… (More)
Is this relevant?
1998
1998
Immune system alterations coexist with modifications in the reproductive axis. The bacterial endotoxin lipopolysaccharide (LPS… (More)
Is this relevant?